Ip W, Bertzbach L, Speiseder T, Dobner T
Tumour Virus Res. 2023; 15:200254.
PMID: 36707050
PMC: 10258410.
DOI: 10.1016/j.tvr.2023.200254.
Mai J, Stubbe M, Hofmann S, Masser S, Dobner T, Boutell C
Microbiol Spectr. 2022; 10(4):e0078522.
PMID: 35699431
PMC: 9431499.
DOI: 10.1128/spectrum.00785-22.
Almuzaini N, Moore M, Robert-Guroff M, Thomas M
Microbiol Spectr. 2022; 10(1):e0188121.
PMID: 35019694
PMC: 8754114.
DOI: 10.1128/spectrum.01881-21.
Reyes E, Kulej K, Pancholi N, Akhtar L, Avgousti D, Kim E
Mol Cell Proteomics. 2017; 16(12):2079-2097.
PMID: 28972080
PMC: 5724173.
DOI: 10.1074/mcp.M117.067116.
Turner R, Groitl P, Dobner T, Ornelles D
J Virol. 2015; 89(9):5083-96.
PMID: 25694601
PMC: 4403466.
DOI: 10.1128/JVI.00213-15.
E1B and E4 oncoproteins of adenovirus antagonize the effect of apoptosis inducing factor.
Turner R, Wilkinson J, Ornelles D
Virology. 2014; 456-457:205-19.
PMID: 24889240
PMC: 4044614.
DOI: 10.1016/j.virol.2014.03.010.
Adenoviral vectors stimulate glucagon transcription in human mesenchymal stem cells expressing pancreatic transcription factors.
Zaldumbide A, Carlotti F, Goncalves M, Knaan-Shanzer S, Cramer S, Roep B
PLoS One. 2012; 7(10):e48093.
PMID: 23110179
PMC: 3482184.
DOI: 10.1371/journal.pone.0048093.
Adenovirus regulates sumoylation of Mre11-Rad50-Nbs1 components through a paralog-specific mechanism.
Sohn S, Hearing P
J Virol. 2012; 86(18):9656-65.
PMID: 22740413
PMC: 3446602.
DOI: 10.1128/JVI.01273-12.
Biophysical and functional analyses suggest that adenovirus E4-ORF3 protein requires higher-order multimerization to function against promyelocytic leukemia protein nuclear bodies.
Patsalo V, Yondola M, Luan B, Shoshani I, Kisker C, Green D
J Biol Chem. 2012; 287(27):22573-83.
PMID: 22573317
PMC: 3391147.
DOI: 10.1074/jbc.M112.344234.
A dynamical systems model for combinatorial cancer therapy enhances oncolytic adenovirus efficacy by MEK-inhibition.
Bagheri N, Shiina M, Lauffenburger D, Korn W
PLoS Comput Biol. 2011; 7(2):e1001085.
PMID: 21379332
PMC: 3040662.
DOI: 10.1371/journal.pcbi.1001085.
Adenovirus core protein VII protects the viral genome from a DNA damage response at early times after infection.
Karen K, Hearing P
J Virol. 2011; 85(9):4135-42.
PMID: 21345950
PMC: 3126275.
DOI: 10.1128/JVI.02540-10.
RNA interference-mediated knockdown of p21(WAF1) enhances anti-tumor cell activity of oncolytic adenoviruses.
Shiina M, Lacher M, Christian C, Korn W
Cancer Gene Ther. 2009; 16(11):810-9.
PMID: 19407849
PMC: 3076587.
DOI: 10.1038/cgt.2009.29.
Temporal regulation of the Mre11-Rad50-Nbs1 complex during adenovirus infection.
Karen K, Hoey P, Young C, Hearing P
J Virol. 2009; 83(9):4565-73.
PMID: 19244322
PMC: 2668508.
DOI: 10.1128/JVI.00042-09.
E4orf1 limits the oncolytic potential of the E1B-55K deletion mutant adenovirus.
Thomas M, Broughton R, Goodrum F, Ornelles D
J Virol. 2009; 83(6):2406-16.
PMID: 19129452
PMC: 2648266.
DOI: 10.1128/JVI.01972-08.
Cellular proteins PML and Daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 protein.
Ullman A, Hearing P
J Virol. 2008; 82(15):7325-35.
PMID: 18480450
PMC: 2493301.
DOI: 10.1128/JVI.00723-08.
Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral response.
Ullman A, Reich N, Hearing P
J Virol. 2007; 81(9):4744-52.
PMID: 17301128
PMC: 1900183.
DOI: 10.1128/JVI.02385-06.
The adenovirus E4 ORF3 protein binds and reorganizes the TRIM family member transcriptional intermediary factor 1 alpha.
Yondola M, Hearing P
J Virol. 2007; 81(8):4264-71.
PMID: 17287283
PMC: 1866117.
DOI: 10.1128/JVI.02629-06.
Diverse roles for E4orf3 at late times of infection revealed in an E1B 55-kilodalton protein mutant background.
Shepard R, Ornelles D
J Virol. 2004; 78(18):9924-35.
PMID: 15331726
PMC: 515017.
DOI: 10.1128/JVI.78.18.9924-9935.2004.